Multiple roles of tumor necrosis factor-alpha in fracture healing

Bone

Volumn 78, Issue , 2015, Pages 87-93

  Karnes, Jonathan M ^a   Daffner, Scott D ^a   Watkins, Colleen M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bone healing; Metabolic bone disease; TNF

Indexed keywords

INTERLEUKIN 1BETA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

AGE; ALCOHOL CONSUMPTION; BONE PROSTHESIS; BONE REMODELING; CALLUS; CELLULAR DISTRIBUTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; METABOLIC BONE DISEASE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOPOROSIS; PROSTHESIS LOOSENING; PROTEIN FUNCTION; REVASCULARIZATION; REVIEW; TRABECULAR BONE; ANIMAL; BONE; BONE DEVELOPMENT; CYTOLOGY; DRINKING BEHAVIOR; FEMALE; FRACTURES, BONE; MESENCHYMAL STROMA CELL; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS;

ALCOHOL DRINKING; ANIMALS; BONE AND BONES; DIABETES MELLITUS; FEMALE; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; MICE; OBESITY; OSTEOGENESIS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938503765     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.05.001     Document Type: Review

References (87)

1. Schell H., et al. The course of bone healing is influenced by the initial shear fixation stability. J Orthop Res 2005, 23(5):1022-1028.
2. Klein P., et al. The initial phase of fracture healing is specifically sensitive to mechanical conditions. J Orthop Res 2003, 21(4):662-669.
3. Lienau J., et al. Initial vascularization and tissue differentiation are influenced by fixation stability. J Orthop Res 2005, 23(3):639-645.
4. Thornton F.J., Schaffer M.R., Barbul A. Wound healing in sepsis and trauma. Shock 1997, 8(6):391-401.
5. Marsell R., Einhorn T.A. The biology of fracture healing. Injury 2011, 42(6):551-555.
6. Kon T., et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001, 16(6):1004-1014.
7. Wahl E.C., et al. Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 2010, 25(1):114-123.
8. Gerstenfeld L.C., et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 2003, 18(9):1584-1592.
9. Sandberg M.M., Aro H.T., Vuorio E.I. Gene expression during bone repair. Clin Orthop Relat Res 1993, 289:292-312.
10. Einhorn T.A., et al. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995, 10(8):1272-1281.
11. Street J., et al. Is human fracture hematoma inherently angiogenic?. Clin Orthop Relat Res 2000, 378:224-237.
12. Grundnes O., Reikeras O. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 1993, 64(3):340-342.
13. Mizuno K., et al. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J Bone Joint Surg (Br) 1990, 72(5):822-829.
14. Caetano-Lopes J., et al. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS ONE 2011, 6(2). [e16947].
15. Currie H.N., et al. Spatial cytokine distribution following traumatic injury. Cytokine 2014, 66(2):112-118.
16. Gerstenfeld L.C., et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003, 88(5):873-884.
17. Lu Z., et al. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation. Stem Cells Dev 2012, 21(13):2420-2429.
18. Frost H.M. The biology of fracture healing. An overview for clinicians. Part I. Clin Orthop Relat Res 1989, 248:283-293.
19. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 355:S7-S21. [Suppl.].
20. Zhou F.H., et al. TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 2006, 21(7):1075-1088.
21. Mountziaris P.M., Tzouanas S.N., Mikos A.G. Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. Biomaterials 2010, 31(7):1666-1675.
22. Harry L.E., et al. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J Orthop Res 2008, 26(9):1238-1244.
23. Khouri R.K., et al. Repair of calvarial defects with flap tissue: role of bone morphogenetic proteins and competent responding tissues. Plast Reconstr Surg 1996, 98(1):103-109.
24. Fu X., et al. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 2009, 17(2):185-191.
25. Zubov D.O. Immunoregulatory role of mesenchymal stem cells in bone reparation processes. Fiziol Zh 2008, 54(4):30-36.
26. Pelissier P., et al. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 2004, 22(1):73-79.
27. Eguchi Y., et al. Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation. J Bone Miner Metab 2010, 28(2):157-164.
28. Zhao Y.P., et al. The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling. Biomaterials 2013, 34(27):6412-6421.
29. Gerstenfeld L.C., et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001, 169(3):285-294.
30. Frost H.M. The biology of fracture healing. An overview for clinicians. Part II. Clin Orthop Relat Res 1989, 248:294-309.
31. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng. Part B Rev. 2008, 14(2):179-186.
32. Bonewald L.F., Mundy G.R. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 1990, 250:261-276.
33. Lind M., et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993, 64(5):553-556.
34. Nielsen H.M., et al. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994, 65(1):37-41.
35. Iwasaki M., et al. Regulation of proliferation and osteochondrogenic differentiation of periosteum-derived cells by transforming growth factor-beta and basic fibroblast growth factor. J Bone Joint Surg Am 1995, 77(4):543-554.
36. Roelen B.A., Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003, 8(5):740-748.
37. Chen Y.J., et al. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004, 22(3):526-534.
38. Waters R.V., et al. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthop Scand 2000, 71(3):316-321.
39. Malviya A., et al. The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study. J Orthop Surg Res 2009, 4:17.
40. Glass G.E., et al. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A 2011, 108(4):1585-1590.
41. Caron M.M., et al. Activation of NF-kappaB/p65 facilitates early chondrogenic differentiation during endochondral ossification. PLoS ONE 2012, 7(3). [e33467].
42. Cho T.J., Gerstenfeld L.C., Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002, 17(3):513-520.
43. Martensson K., Chrysis D., Savendahl L. Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004, 19(11):1805-1812.
44. Breur G.J., et al. Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J Orthop Res 1991, 9(3):348-359.
45. Alblowi J., et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol 2009, 175(4):1574-1585.
46. Lehmann W., et al. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 2005, 36(2):300-310.
47. Kayal R.A., et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res 2010, 25(7):1604-1615.
48. Aizawa T., et al. Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res 2001, 19(5):785-796.
49. Ai-Aql Z.S., et al. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87(2):107-118.
50. Frost A., et al. Inflammatory cytokines regulate proliferation of cultured human osteoblasts. Acta Orthop Scand 1997, 68(2):91-96.
51. Kindle L., et al. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res 2006, 21(2):193-206.
52. Iwakura T., et al. Human hypertrophic nonunion tissue contains mesenchymal progenitor cells with multilineage capacity in vitro. J Orthop Res 2009, 27(2):208-215.
53. Rhinelander F.W. Tibial blood supply in relation to fracture healing. Clin Orthop Relat Res 1974, 105:34-81.
54. Arany L., et al. Arteriographic studies in delayed-union and non-union of fractures. Radiol Diagn (Berl) 1980, 21(5):673-681.
55. Dickson K., et al. Delayed unions and nonunions of open tibial fractures. Correlation with arteriography results. Clin Orthop Relat Res 1994, 302:189-193.
56. Reed A.A., et al. Vascularity in a new model of atrophic nonunion. J Bone Joint Surg (Br) 2003, 85(4):604-610.
57. Reed A.A., et al. Human atrophic fracture non-unions are not avascular. J Orthop Res 2002, 20(3):593-599.
58. Reed A.A.C., et al. Do atrophic non-unions have lower levels of growth factors than hypertrophic non-unions and healing fractures. J Bone Joint Surg 2002, 84-B(Suppl. I):19. (British Volume).
59. Littlewood-Evans A.J., et al. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect Immun 1997, 65(8):3438-3443.
60. Klosterhalfen B., et al. Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. J Trauma 1996, 40(3):372-378.
61. Vallejo J.G., Baker C.J., Edwards M.S. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun 1996, 64(12):5042-5046.
62. Meghji S., et al. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Br J Rheumatol 1998, 37(10):1095-1101.
63. Hashimoto J., et al. Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 1989, 10(6):453-457.
64. Fernandez-Vojvodich P., Karimian E., Savendahl L. The biologics anakinra and etanercept prevent cytokine-induced growth retardation in cultured fetal rat metatarsal bones. Horm Res Paediatr 2011, 76(4):278-285.
65. Li J., et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 2000, 97(4):1566-1571.
66. Fuller K., et al. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002, 143(3):1108-1118.
67. Lam J., et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000, 106(12):1481-1488.
68. Roggia C., et al. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med 2004, 95(2):125-132.
69. Cohen-Solal M.E., et al. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 1993, 77(6):1648-1653.
70. Charatcharoenwitthaya N., et al. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 2007, 22(5):724-729.
71. Murphy A.J., Guyre P.M., Pioli P.A. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol 2010, 184(9):5029-5037.
72. An J., et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A 1999, 96(26):15161-15166.
73. Soysa N.S., Alles N. NF-kappaB functions in osteoclasts. Biochem Biophys Res Commun 2009, 378(1):1-5.
74. Islam A.A., et al. Healing of fractures in osteoporotic rat mandible shown by the expression of bone morphogenetic protein-2 and tumour necrosis factor-alpha. Br J Oral Maxillofac Surg 2005, 43(5):383-391.
75. Cao J.J. Effects of obesity on bone metabolism. J Orthop Surg Res 2011, 6:30.
76. Pedersen M., et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 2003, 124(4):495-502.
77. Bastard J.P., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17(1):4-12.
78. Lu C., et al. Cellular basis for age-related changes in fracture repair. J Orthop Res 2005, 23(6):1300-1307.
79. O'Driscoll S.W., et al. The chondrogenic potential of periosteum decreases with age. J Orthop Res 2001, 19(1):95-103.
80. Mehta M., et al. Influences of age and mechanical stability on volume, microstructure, and mineralization of the fracture callus during bone healing: is osteoclast activity the key to age-related impaired healing?. Bone 2010, 47(2):219-228.
81. Loder R.T. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 1988, 232:210-216.
82. Macey L.R., et al. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 1989, 71(5):722-733.
83. Perrien D.S., et al. IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats. Toxicol Sci 2004, 82(2):656-660.
84. Schwarz E.M., et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000, 18(3):472-480.
85. Merkel K.D., et al. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 1999, 154(1):203-210.
86. Algan S.M., Purdon M., Horowitz S.M. Role of tumor necrosis factor alpha in particulate-induced bone resorption. J Orthop Res 1996, 14(1):30-35.
87. Childs L.M., et al. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001, 16(2):338-347.